Litcius/Paper detail

Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review

Rajat Sarkar, Suvankar Banerjee, Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha

2020European Journal of Medicinal Chemistry117 citationsDOIOpen Access PDF

Topics & Concepts

HDAC3Histone deacetylaseEpigeneticsDrug discoveryHistoneChemistryDrugPharmacologyRheumatoid arthritisComputational biologyCancer researchMedicineBiologyBiochemistryImmunologyGeneHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsClick Chemistry and Applications
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review | Litcius